Ruconest conestat alfa: Completed Phase II enrollment

By WIR Staff | Feb 8, 2016 | 8:00 AM GMT

Pharming completed enrollment of 30 patients deficient in C1 esterase inhibitor

Read the full 112 word article

How to gain access

Continue reading with a
two-week free trial.